Renal Risk Stratification Tool to Guide NOAC Dosing in Patients With Renal Dysfunction
- PMID: 29169486
- DOI: 10.1016/j.jacc.2017.09.1093
Renal Risk Stratification Tool to Guide NOAC Dosing in Patients With Renal Dysfunction
Comment in
-
Reply: NOAC Dosing in Patients With Atrial Fibrillation and Renal Dysfunction.J Am Coll Cardiol. 2017 Nov 28;70(21):2734-2735. doi: 10.1016/j.jacc.2017.09.1092. J Am Coll Cardiol. 2017. PMID: 29169488 No abstract available.
Comment on
-
Non-Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction.J Am Coll Cardiol. 2017 Jun 13;69(23):2779-2790. doi: 10.1016/j.jacc.2017.03.600. J Am Coll Cardiol. 2017. PMID: 28595692
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
